RA
MEDP icon

Rise Advisors’s Medpace MEDP Stock Holding History

Rise Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58
Closed -$29.8K – 899
2025
Q3 		$29.8K Hold
58
– – 0.01% 382
2025
Q2 		$18.2K Hold
58
– – 0.01% 592
2025
Q1 		$17.7K Sell
58
-9
-13% -$3.03K 0.01% 575
2024
Q4 		$22.3K Hold
67
– – 0.01% 582
2024
Q3 		$22.4K Hold
67
– – 0.01% 619
2024
Q2 		$27.6K Hold
67
– – 0.01% 422
2024
Q1 		$27.1K Buy
+67
New +$23.6K 0.01% 438

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Rise Advisors's MEDP Position: Q4 2025 in Review

Rise Advisors sold out of Medpace (MEDP) in Q4 2025, closing a stake of 58 shares — an estimated $29.8K sold.

Rise Advisors first reported a position in MEDP in Q1 2024 and held it in 7 quarters. The position peaked at $29.8K in Q3 2025. 787 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

  • Rise Advisors reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 58 Medpace shares in Q4 2025, an estimated $29.8K.
  • Rise Advisors first reported a position in Medpace in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Medpace position peaked at $29.8K in Q3 2025.
  • 787 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.